Nanotherapeutics

Nanotherapeutics is an integrated biopharmaceutical company with a focus on development and manufacturing. The Company has expertise in preclinical and clinical development, formulation optimization, and cGMP manufacturing of biopharmaceutical products and medical devices. The Company's proprietary platform technologies can be used with all drug types, ranging from small molecules to proteins and vaccines.

Nanotherapeutics has significant expertise in product formulation, scale-up and cGMP manufacturing, utilizing established as well as our proprietary techniques: NanoQUAD®, NanoDRY®, and GelSite®/GelVac™. Our specialized technologies, proprietary processing techniques and know-how set us apart from most other biopharmaceutical companies. Key pharmaceutical advantages of our technologies include:

Broad applicability - Our delivery options are applicable to a diverse group of drug molecules - proteins, peptides and other poorly absorbed compounds.

Versatility of formulation - We have created various types of injectable, inhaled/nasal, topical, and oral formulations using our particle-based delivery expertise.

Stabilization - We have demonstrated more than three years of room temperature stability with different formulations - including vaccines - without loss of activity or dispersability.

Ease of Manufacture - Scale-up to commercial quantities of production is readily obtainable at cost-effective levels.